{"entity":{"id":"dfp-11207","kind":"drug","name":"DFP-11207","aka":[],"tldr":"DFP-11207 is an experimental small molecule from Delta-Fly Pharma, in phase 1 trials for solid tumours; its current status is not stated.","summary":"DFP-11207 is a small molecule (oral, modified 5-FU) from Delta-Fly Pharma. An improved oral 5-FU designed to keep anti-tumour activity without causing a low platelet count. Its furthest stage is phase 1, for solid tumours. ClinicalTrials.gov registers it in one study linked below. Phase 1 NCT02171221 in solid tumours COMPLETED; no later registered trial found. Whether it works in people has not been established unless a trial below reports it.","status":"phase-1","asOf":"2026-11-03","links":[{"label":"Delta-Fly Pharma: delta-flypharma.co.jp","url":"https://www.delta-flypharma.co.jp/en/r-and-d"},{"label":"Delta-Fly Pharma: clinicaltrials.gov","url":"https://clinicaltrials.gov/study/NCT02171221"},{"label":"ClinicalTrials.gov: trials of DFP-11207","url":"https://clinicaltrials.gov/search?intr=DFP-11207"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["delta-fly-pharma"],"institutions":[],"pathways":[],"terms":[],"trials":["nct02171221"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo gap audit, class 5 (company pipeline pages and ClinicalTrials.gov v2)","editedOn":"2026-11-03"},"code":"DFP-11207","modality":"Small molecule (oral, modified 5-FU)","mechanism":"An improved oral 5-FU designed to keep anti-tumour activity without causing a low platelet count.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/dfp-11207/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"delta-fly-pharma","kind":"company","name":"Delta-Fly Pharma","route":"/companies/delta-fly-pharma/"}],"trial":[{"id":"nct02171221","kind":"trial","name":"Phase I Study of Oral DFP-11207 in Solid Tumors","route":"/trials/nct02171221/"}]}}